| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/09/2006 | US7041657 Topical semi-crystalline beta-1,4-n-acetylglucosamine polymers free of proteins and contaminants; stimulating endothelin-1 release, vasoconstriction, and/or reduction in blood flow out of a breached vessel |
| 05/09/2006 | US7041654 Treating or preventing cancer by administering to subject a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence |
| 05/09/2006 | US7041634 Method of inhibiting immune system destruction of transplanted viable cells |
| 05/09/2006 | US7041494 DNA encoding Slo2 and Slo4, potassium channel |
| 05/09/2006 | US7041487 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 05/09/2006 | US7041478 Polypeptide for use in the treatment cancer, inflammation of autoimmune disorders |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041321 supercritically extracting an herb to obtain an oil extract and a residue;extracting the residue in a water/alcohol liquid mixture to obtain a post-supercritical hydroalcoholic extract; evaporating the water/alcohol liquid to form a powdered extract; mixing the powdered extract with the oil extract. |
| 05/09/2006 | US7041312 Wound healing compositions and methods of use |
| 05/09/2006 | US7041291 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | US7040311 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2395653C New inhalable powder containing tiotropium |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/09/2006 | CA2257328C Thiazole derivatives |
| 05/09/2006 | CA2239489C 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity |
| 05/09/2006 | CA2238430C Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 05/09/2006 | CA2175687C A bacterial nitroreductase gene-prodrug system |
| 05/04/2006 | WO2006046779A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
| 05/04/2006 | WO2006046778A1 3-carbamoyl-2-pyridone derivative |
| 05/04/2006 | WO2006046774A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| 05/04/2006 | WO2006046735A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 05/04/2006 | WO2006046623A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 05/04/2006 | WO2006046569A1 Neuronal differentiation promoting peptide |
| 05/04/2006 | WO2006046557A1 Abnormal protein removing composition |
| 05/04/2006 | WO2006046492A1 Novel ppar regulating agent and method of screening the same |
| 05/04/2006 | WO2006045541A1 Treatment and prevention of multi-drug resistance |
| 05/04/2006 | WO2005115461A3 Pharmaceutical composition for modulating the activity of triglyceride hydrolase |
| 05/04/2006 | US20060094879 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 05/04/2006 | US20060094784 Tgf-alpha expression inhibitors |
| 05/04/2006 | US20060094751 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 05/04/2006 | US20060094746 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-hydroxythieno[2,3-c]isoquin-5(4H)-one, used for treating tumor diseases, leukaemia, sarcoma, tissue damage due to ischemia and reperfusion, inflammatory disease, retinal ischemia or brain trauma |
| 05/04/2006 | US20060094743 Isoquinoline compounds and medicinal use thereof |
| 05/04/2006 | US20060094735 Compounds for cell proliferation, anticancer agents, kinesin inbiitors |
| 05/04/2006 | US20060094733 Purine derivatives as liver x receptor agonists |
| 05/04/2006 | US20060094729 metastatic or non-metastatic prostate cancer; for inducing apoptosis |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094724 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 05/04/2006 | US20060094722 Combination drug |
| 05/04/2006 | US20060094718 O-substituted hydroxyaryl derivatives |
| 05/04/2006 | US20060094702 5-HT4 receptor antagonists |
| 05/04/2006 | US20060094691 Inclusion complexes of rosiglitazone |
| 05/04/2006 | US20060094688 Histamine release inhibitor |
| 05/04/2006 | US20060094667 e.g. 1,2-Dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; synergistic mixture with other active compounds |
| 05/04/2006 | US20060094650 Agent for improving life expectancy in therapy of malignant tumor |
| 05/04/2006 | US20060094043 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 05/04/2006 | US20060094013 Salt-inducible kinases 2 and use thereof |
| 05/04/2006 | US20060094012 Polymorphisms for predicting disease and treatment outcome |
| 05/04/2006 | US20060093690 Novel therapeutic use of polypodium extracts |
| 05/04/2006 | US20060093671 Galantamine particles that may be in salt form and an excipient, coated by a release rate controlling membrane; alleviates Alzheimer's dementia and related dementias, when used in amounts insufficient to cause adverse effects |
| 05/04/2006 | US20060093656 Warming patch |
| 05/04/2006 | US20060093612 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 05/04/2006 | US20060093602 Inflammatory mediator antagonists |
| 05/04/2006 | US20060093600 Antibodies to CD40 |
| 05/04/2006 | US20060093598 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 05/04/2006 | US20060093576 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093575 Oxaliplatin anti-resistance agent |
| 05/04/2006 | CA2586474A1 Lamotrigine analogs |
| 05/04/2006 | CA2585642A1 Carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof |
| 05/04/2006 | CA2585638A1 Aminopyridine derivatives having aurora a selective inhibitory action |
| 05/03/2006 | EP1652530A1 Drug promoting ceramide transport, base sequence for producing the drug, method of measuring activity of promoting ceramide release and method of measuring activity of promoting intermembrane ceramide transfer |
| 05/03/2006 | EP1652524A1 Dry syrup containing loratadine |
| 05/03/2006 | EP1652522A1 Sustained release tablet for oral use |
| 05/03/2006 | EP1652518A1 Pharmaceutical composition for sublingual administration |
| 05/03/2006 | EP1652508A1 Adhesive patch |
| 05/03/2006 | EP1651602A2 Aryl heteroaromatic products, compositions comprising the same and use thereof |
| 05/03/2006 | EP1651201A1 Necrosis avid tracer agent |
| 05/03/2006 | EP1572665B1 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 05/03/2006 | EP1543011B1 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
| 05/03/2006 | EP1528923B1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/03/2006 | EP1513836B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 05/03/2006 | EP1499611A4 Process for 5- 2(r)- 1(r)- 3,5-bis(trifluoromethyl)phenyl|ethoxy|-3(s)-(4-fluorophenyl)-4-morpholinyl|methyl|-1,2-dihydro-3h-1,2,4-triazol-3-one |
| 05/03/2006 | EP1465870B1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 05/03/2006 | EP1448986B1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 05/03/2006 | EP1425005B1 Pharmaceutical compostion comprising lumiracoxib |
| 05/03/2006 | EP1390351B1 Pyrimidine derivatives useful as selective cox-2 inhibitors |
| 05/03/2006 | EP1389129A4 Methods of treating respiratory conditions |
| 05/03/2006 | EP1368381B1 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 05/03/2006 | EP1353904B9 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1227805B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1194404B1 Inhibitors of aspartyl protease |
| 05/03/2006 | EP1189611B1 Cancer therapy |
| 05/03/2006 | EP1153017B1 Bicyclic compounds and their use as integrin receptor ligands |
| 05/03/2006 | EP1104309B1 Co-lyophilized complex comprising a nucleic acid vector and a formulating agent |
| 05/03/2006 | EP1074542B1 Sulfonamide-containing indole compounds |
| 05/03/2006 | EP0937069B1 Piperazino derivatives as neurokinin antagonists |
| 05/03/2006 | EP0934326B1 Substituted aminoalkane phosphonic acids |
| 05/03/2006 | EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides |
| 05/03/2006 | CN1768073A Oligosaccharide derivative |
| 05/03/2006 | CN1768065A Thienopyrimidine compound and use of the same |
| 05/03/2006 | CN1767839A Antiallergic composition |
| 05/03/2006 | CN1765890A Modulators of dopamine neurotransmission |
| 05/03/2006 | CN1254543C Method |
| 05/03/2006 | CN1254478C Derivatives of monosaccharides as well adhesion inhibitors |
| 05/03/2006 | CN1254475C 5-methoxy-8-aryl-[1,2,4]triazolo[1,5-a]pyridine derivatives as adenosine receptor antagonists |
| 05/03/2006 | CN1254474C Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |